Cargando…

Patient and general population values for luminal and perianal fistulising Crohn’s disease health states

BACKGROUND: In patients with Crohn’s disease (CD), luminal disease activity paralleled by perianal fistulas may seriously impair health-related quality of life (HRQoL). Health utility values are not available from patients with CD that reflect the health loss associated with both luminal and periana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rencz, Fanni, Stalmeier, Peep F. M., Péntek, Márta, Brodszky, Valentin, Ruzsa, Gábor, Gönczi, Lóránt, Palatka, Károly, Herszényi, László, Schäfer, Eszter, Banai, János, Rutka, Mariann, Gulácsi, László, Lakatos, Peter L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2019
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544586/ https://www.ncbi.nlm.nih.gov/pubmed/31102158 http://dx.doi.org/10.1007/s10198-019-01065-y

Ejemplares similares

The Rituximab Biosimilar CT-P10 in Rheumatology and Cancer: A Budget Impact Analysis in 28 European Countries
por: Gulácsi, László, et al.
Publicado: (2017)

Erratum to: The Rituximab Biosimilar CT-P10 in Rheumatology and Cancer: A Budget Impact Analysis in 28 European Countries
por: Gulácsi, László, et al.
Publicado: (2017)

Validity and reliability of the 9-item Shared Decision Making Questionnaire (SDM-Q-9) in a national survey in Hungary
por: Rencz, Fanni, et al.
Publicado: (2019)

Determinants of the acceptability of health problems in different ages: exploring a new application of the EQ VAS
por: Zrubka, Zsombor, et al.
Publicado: (2019)

Determinants of biological drug survival in rheumatoid arthritis: evidence from a Hungarian rheumatology center over 8 years of retrospective data
por: Brodszky, Valentin, et al.
Publicado: (2017)

Capability of well-being: validation of the Hungarian version of the ICECAP-A and ICECAP-O questionnaires and population normative data
por: Baji, Petra, et al.
Publicado: (2020)

Towards a Central-Eastern European EQ-5D-3L population norm: comparing data from Hungarian, Polish and Slovenian population studies
por: Zrubka, Zsombor, et al.
Publicado: (2019)

Access to biologicals in Crohn’s disease in ten European countries
por: Péntek, Márta, et al.
Publicado: (2017)

Subjective expectations regarding ageing: a cross-sectional online population survey in Hungary
por: Péntek, Márta, et al.
Publicado: (2019)

Acceptable health and ageing: results of a cross-sectional study from Hungary
por: Péntek, Márta, et al.
Publicado: (2020)

Antidrug antibody formation during tumor necrosis factor α inhibitor treatment of severe psoriatic patients in the real-life practice
por: Herszényi, Krisztina, et al.
Publicado: (2019)

Psychometric properties of the Hungarian version of the eHealth Literacy Scale
por: Zrubka, Zsombor, et al.
Publicado: (2019)

Novel Approaches to Ileocolic and Perianal Fistulising Crohn's Disease
por: Luglio, Gaetano, et al.
Publicado: (2018)

Subjective health expectations of patients with age-related macular degeneration treated with antiVEGF drugs
por: Péntek, Márta, et al.
Publicado: (2017)

A comparison of European, Polish, Slovenian and British EQ-5D-3L value sets using a Hungarian sample of 18 chronic diseases
por: Zrubka, Zsombor, et al.
Publicado: (2019)

Assessment of health state utilities in dermatology: an experimental time trade-off value set for the dermatology life quality index
por: Ruzsa, Gábor, et al.
Publicado: (2022)

Subjective well-being in patients with pemphigus: a path analysis
por: Mitev, Ariel, et al.
Publicado: (2019)

Exploring eHealth Literacy and Patient-Reported Experiences With Outpatient Care in the Hungarian General Adult Population: Cross-Sectional Study
por: Zrubka, Zsombor, et al.
Publicado: (2020)

Cost-of-illness studies in nine Central and Eastern European countries
por: Brodszky, Valentin, et al.
Publicado: (2019)

Validation of the Hungarian version of the CarerQol instrument in informal caregivers: results from a cross-sectional survey among the general population in Hungary
por: Baji, Petra, et al.
Publicado: (2020)

Review of local injection of anti-TNF for perianal fistulising Crohn’s disease
por: Adegbola, Samuel O., et al.
Publicado: (2017)

Developing a core outcome set for fistulising perianal Crohn’s disease
por: Sahnan, Kapil, et al.
Publicado: (2019)

ANALYSIS OF THE CLINICAL CHARACTERISTICS OF PERIANAL FISTULISING CROHN’S DISEASE IN A SINGLE CENTER
por: XU, Min-Min, et al.
Publicado: (2019)

Disease monitoring strategies in inflammatory bowel diseases: What do we mean by “tight control”?
por: Gonczi, Lorant, et al.
Publicado: (2019)

Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison
por: Baji, Petra, et al.
Publicado: (2014)

Value Set for the EQ-5D-Y-3L in Hungary
por: Rencz, Fanni, et al.
Publicado: (2022)

Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn’s disease
por: Gu, Bonita, et al.
Publicado: (2022)

Diagnostic performance of texture analysis in the differential diagnosis of perianal fistulising Crohn’s disease and glandular anal fistula
por: Zhu, Xin, et al.
Publicado: (2023)

Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis
por: Baji, Petra, et al.
Publicado: (2014)

Quality of Life and Costs in Parkinson's Disease: A Cross Sectional Study in Hungary
por: Tamás, Gertrúd, et al.
Publicado: (2014)

Health utilities and willingness to pay in adult patients with coeliac disease in Hungary
por: Angyal, M. Mercédesz, et al.
Publicado: (2023)

Ustekinumab is effective for perianal fistulising Crohn's disease: a real-world experience and systematic review with meta-analysis
por: Godoy Brewer, Gala M, et al.
Publicado: (2021)

Combined therapy with early initiation of infliximab following drainage of perianal fistulising Crohn’s disease: a retrospective cohort study
por: Zhu, Ping, et al.
Publicado: (2022)

Is the trend of increasing use of patient-reported outcome measures in medical device studies the sign of shift towards value-based purchasing in Europe?
por: Weszl, Miklós, et al.
Publicado: (2019)

Perianal and Luminal Relapse Following Perianal Surgical Intervention in Crohn’s Disease
por: Deng, Feihong, et al.
Publicado: (2021)

Therapeutic drug monitoring in inflammatory bowel disease: The dawn of reactive monitoring
por: Albader, Farah, et al.
Publicado: (2021)

Prospective randomised controlled trial of adults with perianal fistulising Crohn’s disease and optimised therapeutic infliximab levels: PROACTIVE trial study protocol
por: Gu, Bonita, et al.
Publicado: (2021)

Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe - a Hungarian nationwide observational study
por: Miheller, Pál, et al.
Publicado: (2009)

Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases
por: Gonczi, Lorant, et al.
Publicado: (2017)

Measurement properties of the ICECAP-A capability well-being instrument among dermatological patients
por: Rencz, Fanni, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mred0e44mhm677i0ort2ej60fh